Where does CRISPR go from here?
In just five years, the genome-editing technology CRISPR has been feted, doubted, scrutinized, and subjected to legal review. It has also splintered into a series of related technologies, promising better and more efficient DNA editing. So what’s next?
STAT convened a pair of experts to discuss exactly that, covering the underlying science, the vast potential applications, and the remaining uncertainties tied to the fast-evolving technology. The conversation, moderated by STAT managing editor Gideon Gil, features David Liu, a CRISPR pioneer and professor at the Broad Institute, and Alexis Thompson, a professor of pediatrics at Northwestern University’s Feinberg School of Medicine.
You can watch the discussion here.
STAT convened a pair of experts to discuss exactly that, covering the underlying science, the vast potential applications, and the remaining uncertainties tied to the fast-evolving technology. The conversation, moderated by STAT managing editor Gideon Gil, features David Liu, a CRISPR pioneer and professor at the Broad Institute, and Alexis Thompson, a professor of pediatrics at Northwestern University’s Feinberg School of Medicine.
You can watch the discussion here.
.png)
No hay comentarios:
Publicar un comentario